These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37566741)

  • 1. Tirbanibulin: an alternative topical approach to manage superficial basal cell carcinoma. Comment on: 'Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment'.
    Martora F; Ascierto P; Palla M; Costa C; D'Andrea M; Di Trolio R; Scarpato L; Marasca C
    Clin Exp Dermatol; 2023 Nov; 48(12):1373-1374. PubMed ID: 37566741
    [No Abstract]   [Full Text] [Related]  

  • 2. Tirbanibulin ointment to manage recurrence of superficial basal cell carcinoma of the face: case report.
    Martora F; Ascierto PA; Scalvenzi M; Palla M; Costa C; D'Andrea M; Di Trolio R; Scarpato L; Marasca C
    Clin Exp Dermatol; 2024 Jan; 49(2):183-185. PubMed ID: 37758501
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment.
    Abril-Pérez C; Mansilla-Polo M; Martin-Torregrosa D; Botella-Estrada R
    Clin Exp Dermatol; 2023 Aug; 48(9):1048-1050. PubMed ID: 37146159
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
    Naik MP; Mehta A; Abrol S; Kumar S; Gupta VS
    Orbit; 2016 Dec; 35(6):352-354. PubMed ID: 27715359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 5-fluorouracil (5-FU) ointment on normal and diseased skin. Histological findings and deep action.
    Klostermann GF
    Dermatologica; 1970; 140():Suppl 1:47-54. PubMed ID: 5471361
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical treatment of Kaposi's sarcoma, basal cell carcinoma and solar keratosis with ointment of BCG and cord factor.
    Cohen HA; Bekierkunst A
    Dermatologica; 1979; 158(2):117-25. PubMed ID: 761695
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-fluorouracil (5-FU) ointment in the treatment of basal cell epithelioma. Histological control over a long duration.
    Achten G; Van Oost A; Ledoux-Corbusier M
    Dermatologica; 1970; 140():Suppl 1:59-64. PubMed ID: 5471364
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial.
    Kessels J; Voeten L; Nelemans P; Cleutjens J; Hillen LM; Mosterd K; Kelleners-Smeets NWJ
    JAMA Dermatol; 2017 Oct; 153(10):1061-1063. PubMed ID: 28793140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
    Zala L
    Dermatologica; 1972; 145(5):326-33. PubMed ID: 4654411
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and structural evaluation of the treatment of some hyperplastic and neoplastic skin diseases with 5-fluorouracil (5-FU) ointment.
    Binazzi M
    Dermatologica; 1970; 140():Suppl 1:90-6. PubMed ID: 5471369
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial.
    Brinkhuizen T; Frencken KJ; Nelemans PJ; Hoff ML; Kelleners-Smeets NW; Zur Hausen A; van der Horst MP; Rennspiess D; Winnepenninckx VJ; van Steensel MA; Mosterd K
    J Am Acad Dermatol; 2016 Jul; 75(1):126-34. PubMed ID: 27067393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsurgical therapy holds promise for basal cell carcinoma.
    Oncology (Williston Park); 1999 Jul; 13(7):1044. PubMed ID: 10442350
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.
    Papakostas D; Stockfleth E
    Future Oncol; 2015 Nov; 11(22):2985-90. PubMed ID: 26450707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
    Blauvelt A; Kempers S; Lain E; Schlesinger T; Tyring S; Forman S; Ablon G; Martin G; Wang H; Cutler DL; Fang J; Kwan MR;
    N Engl J Med; 2021 Feb; 384(6):512-520. PubMed ID: 33567191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical immunomodulator against skin cancer. Does the cream replace the knife? (interview by Dr. Judith Neumaier)].
    Hauschild A
    MMW Fortschr Med; 2005 Sep; 147(37):21. PubMed ID: 16193872
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm
    DuBois J; Jones TM; Lee MS; Falqués M; Kiyasova V; Jiménez G; Otero R; Jansat JM; Aubets J; Forconi RJ
    Clin Pharmacol Drug Dev; 2024 Feb; 13(2):208-218. PubMed ID: 38185925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of our trial with 5-fluorouracil (5-FU) ointment on the treatment of basal cell epithelioma and senile keratosis.
    Scarpa C
    Dermatologica; 1970; 140():Suppl 1:114-8. PubMed ID: 5471356
    [No Abstract]   [Full Text] [Related]  

  • 18. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study.
    Reymann F
    Dermatologica; 1979; 158(5):368-72. PubMed ID: 437226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the treatment of superficial neoplasms with 5-FU ointment. Preliminary review].
    Bergonzini R; Vaccari R; Zagnoli P
    G Ital Dermatol Minerva Dermatol; 1970 Feb; 45(2):78-9. PubMed ID: 5467619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.